Skip to main content
AXSM logo
AXSM
(NASDAQ)
Axsome Therapeutics, Inc.
$168.51-- (--)
Loading... - Market loading

Axsome Therapeutics (AXSM) Stock Price & Financial Analysis

Axsome Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$166.65 - $171.22
52-Week High$191.50
52-Week Low$86.99
Open$171.22
Volume617.01K
Average Volume (3M)617.01K
Market Cap8.38B
Shares Outstanding49.75M
Price to Sales (P/S)13.38
Price to Book (P/B)96.78
EV/EBITDA-50.36
Revenue (TTM)638.50M
Net Income (TTM)-183.17M
Free Cash Flow (TTM)-94.17M
EPS (TTM)$-3.62
Profit Margin-28.69%
Operating Margin-25.47%
Return on Equity (ROE)-207.46%
Debt to Equity2.73
50-Day MA$172.29
200-Day MA$139.40
52-Week Change53.83%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Axsome Therapeutics

What is the current stock price for AXSM?

As of the latest trading session, AXSM stock trades at $168.50. The 52-week range is $86.99–$191.50, with a day range of $166.65–$171.22.

What is the P/E ratio for AXSM?

The P/E ratio (Price-to-Earnings) for AXSM is shown in the Key Statistics section. This valuation metric helps compare Axsome Therapeutics, Inc. to industry peers.

Does AXSM pay dividends?

Axsome Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AXSM?

Based on 25 analysts, the consensus for AXSM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AXSM?

Axsome Therapeutics's market capitalization is $8.38B, classifying it as a mid-cap company. Axsome Therapeutics operates in the Healthcare sector within the Biotechnology industry.